TBX2 and breast carcinoma: Using the online tool KM Plotter, we see that TBX2 mRNA expression (as evaluated using 4 different probesets) correlated (significantly in most instances) with poor outcomes in ERα breast cancers and within the Triple Negative Breast Cancer (TNBC) subtype (Supplementary Figure S12).